IxC-162

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameIxC-162
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionOxalates inhibitors
TargetsOxalates
Therapy Area/IndicationsKidney DiseasesCystic FibrosisCrohn Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIxion Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIxion Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsKidney DiseasesCystic FibrosisCrohn Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A